Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean

An antimicrobial consumption (AMC) study was performed in Trinidad and Tobago at the Eastern Regional Health Authority (ERHA). A retrospective, cross-sectional survey was conducted from 1 November 2021 to 30 March 2022. Dosage and package types of amoxicillin, azithromycin, coamoxiclav, cefuroxime,...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagassar, Rajeev P., Jalim, Narin, Mitchell, Arianne, Harrinanan, Ashley, Mohammed, Anisa, Dookeeram, Darren K., Marin, Danini, Giangreco, Lucía, Lichtenberger, Paola, Marín, Gustavo Horacio
Formato: Articulo
Lenguaje:Inglés
Publicado: 2023
Materias:
Ciencias Médicas
antibiotic consumption
Trinidad and Tobago
antibiotics
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/159596
Aporte de:
SEDICI (UNLP) de Universidad Nacional de La Plata
id I19-R120-10915-159596
record_format dspace
spelling I19-R120-10915-1595962023-10-30T20:07:37Z http://sedici.unlp.edu.ar/handle/10915/159596 Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean Nagassar, Rajeev P. Jalim, Narin Mitchell, Arianne Harrinanan, Ashley Mohammed, Anisa Dookeeram, Darren K. Marin, Danini Giangreco, Lucía Lichtenberger, Paola Marín, Gustavo Horacio 2023-04-11 2023-10-30T18:49:47Z en Ciencias Médicas antibiotic consumption Trinidad and Tobago antibiotics An antimicrobial consumption (AMC) study was performed in Trinidad and Tobago at the Eastern Regional Health Authority (ERHA). A retrospective, cross-sectional survey was conducted from 1 November 2021 to 30 March 2022. Dosage and package types of amoxicillin, azithromycin, coamoxiclav, cefuroxime, ciprofloxacin, levofloxacin, moxifloxacin, nitrofurantoin and co-trimoxazole were investigated. Consumption was measured using theWorld Health Organization’s Antimicrobial Resistance and Consumption Surveillance System methodology version 1.0, as defined daily doses (DDD) per 1000 population per day (DID). They were also analyzed using the ‘Access’, ‘Watch’ and ‘Reserve’ classifications. In the ERHA, AMC ranged from 6.9 DID to 4.6 DID. With regards to intravenous formulations, the ‘Watch’ group displayed increased consumption, from 0.160 DID in 2017 to 0.238 DID in 2019, followed by a subsequent drop in consumption with the onset of the COVID-19 pandemic. Oral co-amoxiclav, oral cefuroxime, oral azithromycin and oral co-trimoxazole were the most highly consumed antibiotics. The hospital started off as the higher consumer of antibiotics, but this changed to the community. The consumption of ‘Watch’ group antibiotics increased from 2017 to 2021, with a drop in consumption of ‘Access’ antibiotics and at the onset of COVID-19. Consumption of oral azithromycin was higher in 2021 than 2020. Facultad de Ciencias Médicas Articulo Articulo http://creativecommons.org/licenses/by/4.0/ Creative Commons Attribution 4.0 International (CC BY 4.0) application/pdf
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Ciencias Médicas
antibiotic consumption
Trinidad and Tobago
antibiotics
spellingShingle Ciencias Médicas
antibiotic consumption
Trinidad and Tobago
antibiotics
Nagassar, Rajeev P.
Jalim, Narin
Mitchell, Arianne
Harrinanan, Ashley
Mohammed, Anisa
Dookeeram, Darren K.
Marin, Danini
Giangreco, Lucía
Lichtenberger, Paola
Marín, Gustavo Horacio
Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean
topic_facet Ciencias Médicas
antibiotic consumption
Trinidad and Tobago
antibiotics
description An antimicrobial consumption (AMC) study was performed in Trinidad and Tobago at the Eastern Regional Health Authority (ERHA). A retrospective, cross-sectional survey was conducted from 1 November 2021 to 30 March 2022. Dosage and package types of amoxicillin, azithromycin, coamoxiclav, cefuroxime, ciprofloxacin, levofloxacin, moxifloxacin, nitrofurantoin and co-trimoxazole were investigated. Consumption was measured using theWorld Health Organization’s Antimicrobial Resistance and Consumption Surveillance System methodology version 1.0, as defined daily doses (DDD) per 1000 population per day (DID). They were also analyzed using the ‘Access’, ‘Watch’ and ‘Reserve’ classifications. In the ERHA, AMC ranged from 6.9 DID to 4.6 DID. With regards to intravenous formulations, the ‘Watch’ group displayed increased consumption, from 0.160 DID in 2017 to 0.238 DID in 2019, followed by a subsequent drop in consumption with the onset of the COVID-19 pandemic. Oral co-amoxiclav, oral cefuroxime, oral azithromycin and oral co-trimoxazole were the most highly consumed antibiotics. The hospital started off as the higher consumer of antibiotics, but this changed to the community. The consumption of ‘Watch’ group antibiotics increased from 2017 to 2021, with a drop in consumption of ‘Access’ antibiotics and at the onset of COVID-19. Consumption of oral azithromycin was higher in 2021 than 2020.
format Articulo
Articulo
author Nagassar, Rajeev P.
Jalim, Narin
Mitchell, Arianne
Harrinanan, Ashley
Mohammed, Anisa
Dookeeram, Darren K.
Marin, Danini
Giangreco, Lucía
Lichtenberger, Paola
Marín, Gustavo Horacio
author_facet Nagassar, Rajeev P.
Jalim, Narin
Mitchell, Arianne
Harrinanan, Ashley
Mohammed, Anisa
Dookeeram, Darren K.
Marin, Danini
Giangreco, Lucía
Lichtenberger, Paola
Marín, Gustavo Horacio
author_sort Nagassar, Rajeev P.
title Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean
title_short Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean
title_full Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean
title_fullStr Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean
title_full_unstemmed Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean
title_sort antimicrobial consumption from 2017 to 2021 in east trinidad and tobago: a study in the english-speaking caribbean
publishDate 2023
url http://sedici.unlp.edu.ar/handle/10915/159596
work_keys_str_mv AT nagassarrajeevp antimicrobialconsumptionfrom2017to2021ineasttrinidadandtobagoastudyintheenglishspeakingcaribbean
AT jalimnarin antimicrobialconsumptionfrom2017to2021ineasttrinidadandtobagoastudyintheenglishspeakingcaribbean
AT mitchellarianne antimicrobialconsumptionfrom2017to2021ineasttrinidadandtobagoastudyintheenglishspeakingcaribbean
AT harrinananashley antimicrobialconsumptionfrom2017to2021ineasttrinidadandtobagoastudyintheenglishspeakingcaribbean
AT mohammedanisa antimicrobialconsumptionfrom2017to2021ineasttrinidadandtobagoastudyintheenglishspeakingcaribbean
AT dookeeramdarrenk antimicrobialconsumptionfrom2017to2021ineasttrinidadandtobagoastudyintheenglishspeakingcaribbean
AT marindanini antimicrobialconsumptionfrom2017to2021ineasttrinidadandtobagoastudyintheenglishspeakingcaribbean
AT giangrecolucia antimicrobialconsumptionfrom2017to2021ineasttrinidadandtobagoastudyintheenglishspeakingcaribbean
AT lichtenbergerpaola antimicrobialconsumptionfrom2017to2021ineasttrinidadandtobagoastudyintheenglishspeakingcaribbean
AT maringustavohoracio antimicrobialconsumptionfrom2017to2021ineasttrinidadandtobagoastudyintheenglishspeakingcaribbean
_version_ 1807221705025781760

Ejemplares similares